AGM
Alpine Global Management Portfolio holdings
AUM
$436M
1-Year Return
37.82%
This Quarter Return
-1.78%
1 Year Return
+37.82%
3 Year Return
+131.76%
5 Year Return
+262.91%
10 Year Return
+699.1%
AUM
$575M
AUM Growth
+$58.8M
(+11%)
Cap. Flow
+$68.6M
Cap. Flow
% of AUM
11.94%
Top 10 Holdings %
Top 10 Hldgs %
36.71%
Holding
556
New
357
Increased
46
Reduced
31
Closed
94
Top Buys
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
$26.5M |
| 2 |
Microsoft
MSFT
|
$9.78M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$6.84M |
| 4 |
Archer Aviation
ACHR
|
$6.4M |
| 5 |
Applied Materials
AMAT
|
$5.47M |
Top Sells
| 1 |
AGTI
Agiliti, Inc.
AGTI
|
$26.4M |
| 2 |
Robinhood
HOOD
|
$22.7M |
| 3 |
CPE
Callon Petroleum Company
CPE
|
$17.7M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$11.7M |
| 5 |
CRH
CRH
|
$7.76M |
Sector Composition
| 1 | Healthcare | 17.25% |
| 2 | Technology | 14.7% |
| 3 | Financials | 8.94% |
| 4 | Industrials | 5.39% |
| 5 | Communication Services | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cullinan Oncology
CGEM
$408M
| $212K | 0.04% |
+12,164
| New | +$212K |
|
277
BioAtla
BCAB
$29.3M
| $212K | 0.04% |
+154,417
| New | +$212K |
|
278
Natural Gas Services Group
NGS
$340M
| $210K | 0.04% |
+10,446
| New | +$210K |
|
279
Mama's Creations
MAMA
$354M
| $210K | 0.04% |
+31,164
| New | +$210K |
|
280
Bioventus
BVS
$475M
| $209K | 0.04% |
+36,370
| New | +$209K |
|
281
Enovix
ENVX
$1.77B
| $207K | 0.04% |
+15,291
| New | +$207K |
|
282
Amylyx Pharmaceuticals
AMLX
$887M
| $207K | 0.04% |
+108,862
| New | +$207K |
|
283
BioMarin Pharmaceuticals
BMRN
$10.9B
| $206K | 0.04% |
+2,504
| New | +$206K |
|
284
NET Power
NPWR
$174M
| $204K | 0.04% |
+20,748
| New | +$204K |
|
285
Inovio Pharmaceuticals
INO
$146M
| $201K | 0.04% |
+24,916
| New | +$201K |
|
286
Thermo Fisher Scientific
TMO
$185B
| $201K | 0.04% |
+364
| New | +$201K |
|
287
Blue Ridge Bankshares
BRBS
$372M
| $201K | 0.03% |
76,900
| – | – |
|
288
ARS Pharmaceuticals
SPRY
$1.06B
| $199K | 0.03% |
+23,435
| New | +$199K |
|
289
Aclaris Therapeutics
ACRS
$224M
| $196K | 0.03% |
+177,909
| New | +$196K |
|
290
Ivanhoe Electric
IE
$1.18B
| $191K | 0.03% |
+20,353
| New | +$191K |
|
291
Aquestive Therapeutics
AQST
$612M
| $188K | 0.03% |
+72,177
| New | +$188K |
|
|
TE
292
T1 Energy Inc.
TE
$288M
| $187K | 0.03% |
+110,002
| New | +$187K |
|
293
Sana Biotechnology
SANA
$757M
| $187K | 0.03% |
+34,181
| New | +$187K |
|
|
MITT
294
AG Mortgage Investment Trust
MITT
$248M
| $186K | 0.03% |
+28,082
| New | +$186K |
|
295
Perella Weinberg Partners
PWP
$1.39B
| $181K | 0.03% |
+11,138
| New | +$181K |
|
|
VIGL
296
DELISTED
Vigil Neuroscience
VIGL
| $180K | 0.03% |
+44,893
| New | +$180K |
|
297
Viridian Therapeutics
VRDN
$1.52B
| $179K | 0.03% |
+13,794
| New | +$179K |
|
298
BlackRock MuniVest Fund
MVF
$371M
| $179K | 0.03% |
+25,000
| New | +$179K |
|
299
Inhibrx
INBX
$402M
| $176K | 0.03% |
+12,445
| New | +$176K |
|
|
ASA
300
ASA Gold and Precious Metals
ASA
$722M
| $175K | 0.03% |
+10,000
| New | +$175K |
|